Pathstone Holdings
CRBU icon

Pathstone Holdings’s Caribou Biosciences CRBU Stock Holding History

Pathstone Holdings’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,011
Closed -$16.4K – 2349
2025
Q2 		$16.4K Sell
13,011
-9,159
-41% -$9.01K ﹤0.01% 2173
2025
Q1 		$20.2K Hold
22,170
– – ﹤0.01% 2206
2024
Q4 		$35.3K Sell
22,170
-5,076
-19% -$10.2K ﹤0.01% 2277
2024
Q3 		$53.4K Buy
+27,246
New +$55.8K ﹤0.01% 2281

Other funds holding CRBU

P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pathstone Holdings's CRBU Position: Q3 2025 in Review

Pathstone Holdings sold out of Caribou Biosciences (CRBU) in Q3 2025, closing a stake of 13,011 shares — an estimated $16.4K sold.

Pathstone Holdings first reported a position in CRBU in Q3 2024 and held it in 4 quarters. The position peaked at $53.4K in Q3 2024. 117 funds tracked by Wall St. Rank hold CRBU as of Q3 2025.

  • Pathstone Holdings reported no remaining Caribou Biosciences position as of Q3 2025 after selling out during the quarter.
  • Pathstone Holdings sold 13,011 Caribou Biosciences shares in Q3 2025, an estimated $16.4K.
  • Pathstone Holdings first reported a position in Caribou Biosciences in Q3 2024 and held it in 4 quarters.
  • Pathstone Holdings's Caribou Biosciences position peaked at $53.4K in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2025.

Based on Pathstone Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.